Search by :


Non-invasive Prenatal Testing 27-09-2017
Patient Brochures

When you are pregnant, your blood contains fragments of your baby's DNA. A non-invasive prenatal test analyses this DNA in a sample of your blood, to assess the chance of trisomy 21  (Down syndrome) and two other genetic conditions, trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome). While some genetic conditions run in families, these chromosomal disorders typically do not. They can happen in any pregnancy. Although the chance of such conditions increases with age, most babies with Down syndrome are born to women under 35 years of age.

Critical Result Values 11-10-2017
Doctor Bulletins

Critical values are those results that may indicate a life threatening medical condition and require immediate notification to the referring doctor (irrespective of whether the pathology request was marked urgent).

If a result outside the critical limits is obtained, a scientist or pathologist will make every attempt to contact the referring doctor.

Sweat Test 26-10-2017
Patient Test Collection Instructions
What is a sweat test? A sweat test measures the amount of chloride in a person's sweat.
Syzygy November 2017 27-10-2017

In this edition of Syzygy:

  • Fetal fraction: the essential factor in non-invasive prenatal testing - an article by Dr James Harraway, pathologist-in-charge, Genetics.
  • Female study links low vitamin D and multiple sclerosis risk - an article by Dr Daman Langguth, pathologist-in-charge, Immunology.
  • Pathologist profile: Dr Sarah Sim
  • New weekly clostridium difficile reports now available online
  • Update to cervical screening program changes
Therapeutic Drug Test 27-10-2017
Patient Test Collection Instructions
Measurement of therapeutic drug levels is usually only necessary for drugs with a 'narrow therapeutic window': that is, where too much of the drug may be toxic, and too little of the drug will be ineffective
Anti-CCP (Cyclic Citrullinated Peptides) 15-11-2017
Doctor Bulletins

Research in Rheumatoid Arthritis (RA) over the last 10 years has gained significant ground in both pathophysiological and clinical understanding. It is now known that early aggressive therapy within  the first 3 months of the development of joint symptoms decreases the chance of developing severe disease, both clinically and radiologically. To enable this early diagnosis, there has been  considerable effort made to discover serologic markers of disease.

Genetic testing for the breast cancer gene 15-11-2017
Patient Brochures

This information sheet addresses some of the more common questions associated with BRCA1 and BRCA2 testing, and provides links to useful websites.

Urine collection: Cytology 15-11-2017
Patient Test Collection Instructions
Note: The first specimen of urine for the day is not suitable for cytology. The specimen can be taken at any other time of the day.
Page 15 of 15
<<first | prev | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 | next | last>>